Brought to you by Applied Clinical Trials, The Clinical Data Disclosure and Transparency Resource Community is the go-to web destination for comprehensive data disclosure and transparency content.
Citeline Data Shows Higher Rate of Transparency Commitment
Sept. 10, 2014
TransCelerate Issues its CSR Redaction Approach for Data Sharing
Sept. 3, 2014
ECGCP Warns About Risks of Overprotecting Data
Aug. 1, 2014
ESMO's Concerns Over Data Protection and Research
July 25, 2014
Catching Up with Data Protection
July 21, 2014
EMA Delays Decision on Clinical Trial Data Until October
July 10, 2014
Pharma Improves Care by Sharing Clinical Trial Data
June 17, 2014
Privacy Analytics Launches Transparency Solution
June 18, 2014
Clinical Data Disclosure and Transparency
January 28-29, 2015 | Philadelphia, Pennsylvania
CBI’s successful inaugural event focusing on Clinical Data Disclosure and Transparency is back for its second year! This conference is the biggest of its kind and brings together high level executives to discuss and disseminate aspects of required data disclosure in a time of industry reform. Facing heightened pressure from the EMA, NIH, EFPIA, PhRMA and ICMJE to disclose clinical trial results and be transparent about all clinical trial data, this program focuses on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.